Verinnogen is a startup based in the United Kingdom, most recent round Series A, 2 tracked investors.
Verinnogen is a company founded in 2021 headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Verinnogen develops handheld 3D surface profiling technology to measure subcutaneous tumors in preclinical cancer research, improving accuracy and repeatability to accelerate drug development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.